|
(2R,4S,5R,6R)- 5- Acetamido- 2- [[(2R,3R,4S,5R,6S)- 6- [(2R,3S,4R,5R)- 5- acetamido- 6- hydroxy- 2- (hydroxymethyl)- 4- [(2S,3S,4R,5S,6S)- 3,4,5- trihydroxy- 6- methyloxan- 2- yl]oxyoxan- 3- yl]oxy- 3,4,5- trihydroxyoxan- 2- yl]methoxy]- 4- hydroxy- 6- [(1R,2R)- 1,2,3- trihydroxypropyl]oxane- 2- carboxylic acid |
|
CHEBI:155732 |
|
 
This entity has been manually annotated by a third party.
|
|
Gareth Owen
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C31H52N2O23/c1- 8- 17(40) 20(43) 22(45) 28(51- 8) 55- 26- 16(33- 10(3) 37) 27(47) 52- 13(6- 35) 24(26) 54- 29- 23(46) 21(44) 19(42) 14(53- 29) 7- 50- 31(30(48) 49) 4- 11(38) 15(32- 9(2) 36) 25(56- 31) 18(41) 12(39) 5- 34/h8,11- 29,34- 35,38- 47H,4- 7H2,1- 3H3,(H,32,36) (H,33,37) (H,48,49) /t8- ,11- ,12+,13+,14+,15+,16+,17+,18+,19- ,20+,21- ,22- ,23+,24+,25+,26+,27?,28- ,29- ,31+/m0/s1 |
JVKIVQYGPSAWBB-WVJLIFNXSA-N |
O([C@H] 1[C@H] (O[C@@H] 2O[C@H] ([C@@H] (O) [C@@H] (O) [C@@H] 2O) C) [C@@H] (NC(=O) C) C(O[C@@H] 1CO) O) [C@@H] 3O[C@@H] ([C@H] (O) [C@H] (O) [C@H] 3O) CO[C@] 4(O[C@H] ([C@H] (NC(=O) C) [C@@H] (O) C4) [C@H] (O) [C@H] (O) CO) C(O) =O |
|
Outgoing
|
(2R,4S,5R,6R)- 5- Acetamido- 2- [[(2R,3R,4S,5R,6S)- 6- [(2R,3S,4R,5R)- 5- acetamido- 6- hydroxy- 2- (hydroxymethyl)- 4- [(2S,3S,4R,5S,6S)- 3,4,5- trihydroxy- 6- methyloxan- 2- yl]oxyoxan- 3- yl]oxy- 3,4,5- trihydroxyoxan- 2- yl]methoxy]- 4- hydroxy- 6- [(1R,2R)- 1,2,3- trihydroxypropyl]oxane- 2- carboxylic acid
(CHEBI:155732)
is a
neuraminic acids
(CHEBI:25508)
|
|
5- acetamido- 3,5- dideoxy- D- glycero- alpha- D- galacto- non- 2- ulopyranosylonic acid- (2- >6)- beta- D- galacto- hexopyranosyl- (1- >4)- [6- deoxy- alpha- L- galacto- hexopyranosyl- (1- >3)]- 2- acetamido- 2- deoxy- D- gluco- hexopyranose
|
SUBMITTER
|
NeuAc(a2-6)Gal(b1-4)[Fuc(a1-3)]GlcNAc
|
SUBMITTER
|
WURCS=2.0/4,4,3/[a2122h- 1x_1- 5_2*NCC/3=O][a1221m- 1a_1- 5][a2112h- 1b_1- 5][Aad21122h- 2a_2- 6_5*NCC/3=O]/1- 2- 3- 4/a3- b1_a4- c1_c6- d2
|
SUBMITTER
|
|